Genome & Company (KOSDAQ:314130)
South Korea
· Delayed Price · Currency is KRW 2,700.00
+85.00 (3.25%)
At close: Aug 11, 2025, 3:30 PM KST
-47.98% (1Y)
| Market Cap | 84.09B |
| Revenue (ttm) | 29.84B |
| Net Income (ttm) | -19.04B |
| Shares Out | 31.09M |
| EPS (ttm) | -619.34 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 112,486 |
| Average Volume | 161,999 |
| Open | 2,620.00 |
| Previous Close | 2,615.00 |
| Day's Range | 2,590.00 - 2,700.00 |
| 52-Week Range | 2,170.00 - 5,600.00 |
| Beta | 1.13 |
| RSI | 44.55 |
| Earnings Date | Aug 14, 2025 |